BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.57B |
| 2 |
Tesla
TSLA
|
+$781M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$657M |
| 4 |
Advanced Micro Devices
AMD
|
+$646M |
| 5 |
ExxonMobil
XOM
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.23B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$667M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$592M |
| 4 |
Broadcom
AVGO
|
+$588M |
| 5 |
Texas Instruments
TXN
|
+$524M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.09% |
| 2 | Financials | 6.69% |
| 3 | Consumer Discretionary | 5.99% |
| 4 | Healthcare | 5.68% |
| 5 | Industrials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Usana Health Sciences
USNA
$252M
| $263K | ﹤0.01% |
12,326
+7,525
| +157% | +$141K |
|
3977
XPEL
XPEL
$1.39B
| $263K | ﹤0.01% |
5,304
-820
| -13% | -$37.3K |
|
3978
Harrow
HROW
$1.46B
| $261K | ﹤0.01% |
6,151
-1,855
| -23% | -$69K |
|
3979
JELD-WEN Holding
JELD
$170M
| $261K | ﹤0.01% |
173,888
+156,833
| +920% | +$242K |
|
3980
Southside Bancshares
SBSI
$984M
| $261K | ﹤0.01% |
7,403
+716
| +11% | +$23.7K |
|
|
TVAI
3981
Thayer Ventures Acquisition Corporation II
TVAI
$283M
| $260K | ﹤0.01% |
25,193
| – | – |
|
|
PLGO
3982
Pelagos Insurance Capital
PLGO
$1.95B
| $260K | ﹤0.01% |
10,697
-7,846
| -42% | -$171K |
|
|
WENN
3983
Wen Acquisition Corp
WENN
$389M
| $260K | ﹤0.01% |
25,274
| – | – |
|
3984
ZipRecruiter
ZIP
$388M
| $260K | ﹤0.01% |
69,296
-44,382
| -39% | -$138K |
|
3985
Acco Brands
ACCO
$399M
| $260K | ﹤0.01% |
62,461
+24,539
| +65% | +$90.1K |
|
|
ORC
3986
Orchid Island Capital
ORC
$1.32B
| $259K | ﹤0.01% |
37,214
-4,994
| -12% | -$34.4K |
|
|
ATII
3987
Archimedes Tech SPAC Partners II Co
ATII
$315M
| $256K | ﹤0.01% |
23,790
-13,954
| -37% | -$152K |
|
3988
Vanguard Morningstar Large-Cap ETF
VV
$54.9B
| $256K | ﹤0.01% |
744
+737
| +10,529% | +$246K |
|
|
AAT
3989
American Assets Trust
AAT
$1.41B
| $255K | ﹤0.01% |
10,326
-4,547
| -31% | -$99.7K |
|
3990
Capricor Therapeutics
CAPR
$244M
| $255K | ﹤0.01% |
10,579
-3,421
| -24% | -$104K |
|
|
PSIX
3991
Power Solutions International
PSIX
$947M
| $255K | ﹤0.01% |
6,550
-6,611
| -50% | -$363K |
|
3992
Universal Corp
UVV
$1.12B
| $254K | ﹤0.01% |
4,869
-12,907
| -73% | -$687K |
|
3993
Genius Sports
GENI
$2.2B
| $254K | ﹤0.01% |
41,851
-7,647
| -15% | -$39.6K |
|
3994
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
| $253K | ﹤0.01% |
8,205
+8,201
| +205,025% | +$252K |
|
3995
Novavax
NVAX
$1.34B
| $252K | ﹤0.01% |
26,771
-314,900
| -92% | -$2.82M |
|
3996
Magna International
MGA
$18.7B
| $252K | ﹤0.01% |
3,836
-26,573
| -87% | -$1.66M |
|
3997
UBS Group
UBS
$176B
| $252K | ﹤0.01% |
5,082
-257,101
| -98% | -$11.7M |
|
3998
Navient
NAVI
$867M
| $252K | ﹤0.01% |
29,587
-142,802
| -83% | -$1.2M |
|
3999
AMN Healthcare
AMN
$1.34B
| $252K | ﹤0.01% |
7,776
-70,209
| -90% | -$1.81M |
|
4000
PUT
VeriSign
VRSN
$26B
| $252K | ﹤0.01% |
+10
| New | +$2.78K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2026 Portfolio in Review
As of Q2 2026, BNP Paribas Financial Markets held 6,280 positions worth $289B, up 40% from $206B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets's Q2 2026 filing shows 491 new, 2,324 increased, 2,334 reduced and 375 closed positions. Its largest new stake was Honeywell Aerospace: 869,061 shares worth $192M. The largest sale was Microsoft, an estimated $2.23B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2026 buy was Honeywell Aerospace: 869,061 shares worth $192M.
- BNP Paribas Financial Markets added most to Micron Technology in Q2 2026, an estimated $2.57B increase.
- BNP Paribas Financial Markets's biggest Q2 2026 reduction was Microsoft, cutting an estimated $2.23B.
- BNP Paribas Financial Markets fully exited Coterra Energy in Q2 2026, selling an estimated $57.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $289B portfolio in Q2 2026.
- BNP Paribas Financial Markets opened 491 new positions and closed 375 in Q2 2026.
- BNP Paribas Financial Markets's portfolio value rose 40% quarter-over-quarter to $289B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.